Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Rev. bras. cir. cardiovasc ; 39(4): e20240138, 2024. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1559404

RESUMO

ABSTRACT Congenital heart disease (CHD) affects eight to ten out of every 1,000 births, resulting in approximately 23,057 new cases in Brazil in 2022. About one in four children with CHD requires surgery or other procedures in the first year of life, and it is expected that approximately 81% of these children with CHD will survive until at least 35 years of age. Professionals choosing to specialize in CHD surgery face numerous challenges, not only related to mastering surgical techniques and the complexity of the diseases but also to the lack of recognition by medical societies as a separate subspecialty. Furthermore, families face difficulties when access to services capable of providing treatment for these children. To address these challenges, it is essential to have specialized hospitals, qualified professionals, updated technologies, sustainable industry, appropriate financing, quality assessment systems, and knowledge generation. The path to excellence involves specialization across all involved parties. As we reflect on the importance of Pediatric Cardiovascular Surgery and Congenital Heart Diseases establishing themselves as a subspecialty of Cardiovascular Surgery, it is essential to look beyond our borders to countries like the United States of America and United Kingdom, where this evolution is already a reality. This autonomy has led to significant advancements in research, education, and patient care outcomes, establishing a care model. By following this path in Brazil, we not only align our practice with the highest international standards but also demonstrate our maturity and the ability to meet the specific needs of patients with CHD and those with acquired childhood heart disease.

2.
Medicina (Ribeirao Preto, Online) ; 55(2)abr. 2022. tab, ilus
Artigo em Inglês | LILACS | ID: biblio-1402527

RESUMO

The Brazilian Society of Neurological Research (SBIN) was founded on December 19, 2000, by a group of neurol-ogists headed by Professor Lineu César Werneck, MD, Ph.D., to promote scientific development and cultural diver-sity in neurology and neurosciences. The criteria for members' admission have always been strict, and the group reached 80% of physicians with a Ph.D. degree. However, the conditions to become a member were modified to attract more researchers, especially the younger ones, and neuroscientists from other areas of health and biology. The scientific events were the primary goal of SBIN. Eighteen editions were performed. The board and members of the SBIN recognized that the Brazilian Academy of Neurology, and the other societies that encouraged the neuro-sciences, were working to continue the exponential increase of scientific production in the neurosciences in Brazil, realizing that their purposes were fulfilled. The society was dissolved in December 2020 (AU)


A Sociedade Brasileira de Investigação Neurológica (SBIN) foi fundada em 19 de dezembro de 2000 por um grupo de neurologistas capitaneados pelo Prof. Dr. Lineu César Werneck, com a finalidade de promover o desenvolvimento científico e cultural na neurologia e nas neurociências. Os critérios de admissão de membros sempre foram rígi-dos, tendo o grupo alcançado 80% de médicos com doutorado. Entretanto, as condições para se tornar membro foram modificadas com a intenção de atrair mais pesquisadores, principalmente os mais jovens, e neurocientistas de outras áreas da saúde e da biologia. Os eventos científicos foram o objetivo maior da SBIN. Foram realizadas 18 edições. A diretoria e os membros da SBIN reconheceram que a Academia Brasileira de Neurologia, e as outras sociedades de incentivo às neurociências, estavam trabalhando para a continuidade do aumento exponencial da produção científica em ciências neurológicas no Brasil, compreendendo que seus propósitos estavam cumpridos. A sociedade se desfez em dezembro de 202 (AU)


Assuntos
Sociedades Médicas , Sociedades Científicas , Neurociências , Ensaio , História da Medicina
3.
Rev. bras. cir. cardiovasc ; 37(1): 99-109, Jan.-Feb. 2022. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1365546

RESUMO

ABSTRACT Introduction: The primary aim of this systematic review is to provide perioperative strategies to help restore or preserve cardiovascular services under threat from financial and personnel constraints imposed by the coronavirus disease 2019 (COVID-19) pandemic. Methods: The Medical Literature Analysis and Retrieval System Online, Excerpta Medica dataBASE, Cochrane Central Register of Controlled Trials/CCTR, and Google Scholar were systematically searched using the search terms "(cardiac OR cardiology OR cardiothoracic OR surgery) AND (COVID-19 or coronavirus OR SARS-CoV-2 OR 2019-nCoV OR 2019 novel coronavirus OR pandemic)". Additionally, the webpages of relevant medical societies, including the World Federation Society of Anesthesiologists, the Cardiothoracic Surgery Network, and the Society of Thoracic Surgeons, were screened for relevant information. Results: Whereas cardiac surgery and cardiology practices were reduced by 50-75% during the pandemic, mortality of patients with COVID-19 increased significantly. Healthcare workers are among those at high risk of infection with COVID-19. Conclusion: Hospitals must provide maximum protective equipment and training on how to use it to healthcare workers for their mutual protection. Triage management of patients — which accounts for patient's clinical status and risk-factor profile relatable to which services are available during the COVID-19 pandemic — is recommended. A strict reorganization of the hospital resources including preoperative, intraoperative, and postoperative detailed protective measures is necessary to reduce probability of vector contamination, to protect patients and the cardiovascular teams, and to permit safe resumption of cardiological and cardiac surgical activity.

4.
Arq. gastroenterol ; 57(supl.1): 1-20, 2020. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1098067

RESUMO

ABSTRACT Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2015 its first recommendations about the management of HCC. Since then, new data have emerged in the literature, prompting the governing board of SBH to sponsor a single-topic meeting in August 2018 in São Paulo. All the invited experts were asked to make a systematic review of the literature reviewing the management of HCC in subjects with cirrhosis. After the meeting, all panelists gathered together for the discussion of the topics and the elaboration of updated recommendations. The text was subsequently submitted for suggestions and approval of all members of the Brazilian Society of Hepatology through its homepage. The present manuscript is the final version of the reviewed manuscript containing the recommendations of SBH.


RESUMO O carcinoma hepatocelular (CHC) é uma das principais causas de mortalidade relacionada a câncer no Brasil e no mundo. A Sociedade Brasileira de Hepatologia (SBH) publicou em 2015 suas primeiras recomendações sobre a abordagem do CHC. Desde então, novas evidências sobre o diagnóstico e tratamento do CHC foram relatadas na literatura médica, levando a diretoria da SBH a promover uma reunião monotemática sobre câncer primário de fígado em agosto de 2018 com o intuito de atualizar as recomendações sobre o manejo da neoplasia. Um grupo de experts foi convidado para realizar uma revisão sistemática da literatura e apresentar uma atualização baseada em evidências científicas visando que pudesse nortear a prática clínica multidisciplinar do CHC. O texto resultante foi submetido a avaliação e aprovação de todos membros da SBH através de sua homepage. O documento atual é a versão final que contêm as recomendações atualizadas e revisadas da SBH.


Assuntos
Humanos , Carcinoma Hepatocelular/diagnóstico , Carcinoma Hepatocelular/terapia , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/terapia , Sociedades Médicas , Brasil/epidemiologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/epidemiologia , Medicina Baseada em Evidências , Revisões Sistemáticas como Assunto , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/epidemiologia , Inoculação de Neoplasia
5.
Medisan ; 21(8)ago. 2017.
Artigo em Espanhol | LILACS | ID: biblio-997632

RESUMO

En Santiago de Cuba, los días 25 y 26 de mayo de este año, se realizó la X Jornada Científica Provincial de los Servicios Médicos del Ministerio del Interior, bajo el auspicio del Capítulo Provincial de la Sociedad de Medicina General Integral y con el objetivo principal de fomentar el intercambio de experiencias, el diálogo y la comunicación científica entre sus participantes. Al evento asistieron 118 delegados, entre ellos, médicos especialistas y residentes de diversas ramas, así como estomatólogos, enfermeras, psicólogos y demás profesionales de la salud que hoy laboran en los servicios médicos de dicho Ministerio a lo largo y ancho de todo el territorio santiaguero.


On May 25th and 26th of this year, the X Provincial Scientific Event of the Ministry of Interior Medical Services was carried out in Santiago de Cuba, under the sponsoring of the Comprehensive General Medicine Society Provincial Chapter, and with the main objective of fomenting the exchange of experiences, the dialogue and the scientific communication among its participants. One hundred and eighteen delegates attended the event, among them, specialist and resident doctors of several branches, as well as stomatologists, nurses, psychologists and other health professionals who work at present in the medical services of this Ministry through the whole territory from Santiago.


Assuntos
Humanos , Masculino , Feminino , Eventos Científicos e de Divulgação , Comunicação e Divulgação Científica , Medicina Militar , Prisioneiros , Exposições Científicas
6.
Medical Education ; : 29-35, 2008.
Artigo em Japonês | WPRIM | ID: wpr-370024

RESUMO

1) To improve the quality of medical care and to ensure patient safety, physicians have the professional duty and responsibility to constantly study the newest medical knowledge and technology.<BR>2) The terminology for “continuing education”for physicians differs in meaning from that generally used to refer to “life-long education.”<BR>3) Continuing medical education (CME) in Japan is independently carried out by medical associations and by numerous academic medical societies. Present CME activities in Japan are reviewed, and CME in the United States is explained.<BR>4) Continuing professional development is introduced as a new paradigm of CME for physicians, created to improve the health-care system in the United Kingdom.<BR>5) To further improve CME for physicians in Japan, prospective issues are discussed. Establishment of a third-party organization that discusses, manages, and operates the CME system for physicians, is strongly recommended.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA